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ABSTRACT
An approach for desigining arterial stents to maximize wall shear stress is presented. A
cost equation to maximize wall shear stress is derived and then inverted into a minimization
problem for the optimizer. A 2-D mixed-element finite-volume scheme for solving the
compressible Navier-Stokes equations is implemented. A paramaterization of the cross-
sectional shape of the stent wire using Hicks-Henne functions is described. The strategies
used in the commercial optimization software, DAKOTA, to minimize the cost equation are
described. The solver is validated using well known fluid flow test cases and is shown to match
other published computed results for bloodflow through stented arteries. New candidate stent
shapes are produced by the optimization and are evaluated based on comparison to modern
commercial stent designs.
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LIST OF MEDICAL TERMINOLOGY
atherosclerosis - The condition in which fat, cholesterol, and other substances builds up on
the arterial walls to form plaques which can eventually block the artery and cause other
problems throughout the circulatory system.
percutaneous coronary intervention (PCI) - Also known as coronary angioplasty or angio-
plasty is a non-surgical procedure used to treat stenotic (narrowed) arteries. A deflated
angioplasty balloon is inserted into the artery and inflated where the blockage is, removing
the plaque and restoring blood flow through the artery. The damage to the arterial wall
from the plaque and the inflation of the balloon often necessitate the use of an stent.
stent - A cylindrical, mesh-like, metal or plastic tube which is inserted into a damaged blood
vessel to help maintain the structure of the vessel walls.
stenosis - A narrowing of the of the opening of a blood vessel.
restenosis - The condition in which plaque reforms in a blood vessel that has been treated
for atherosclerosis.
in-stent restenosis - The condition in which plaque build up on top of the stent after
treatment for atherosclerosis.
intima - The inner lining of a blood vessel. It is made up of the endothelium, the
subendothelial layer, and an elastic layer.
endothelium - The thin layer of cells which lines the interior of blood vessels. These cells are
called endothelial cells.
endothelialization - The formation of endothelial tissue. When this process is complete, the
injurt to the blood vessel is considered to have been healed.
(neointimal) hyperplasia - The thickening of the intima of a blood vessel as a response to
injury.
xiii
elastic recoil - In relation to blood vessels, elastic recoil is the tendency of the blood vessel
wall to revert to the deformed shape after injury.
smooth muscle cells - The cellular components of the blood vessel wall responsible for
providing structural integrity. In response to injury, the smooth muscle cells (SMCs) also
synthesize extracellular matrix molecules, migrate, and proliferate.
extracellular matrix - Molecules which help maintain the structure of the vessel wall. They
aid in the formation of scar tissue, but in excess can lead to fibrosis.
fibrosis - The reparative or reactive response to injury resulting in the formation of connective
tissue. This refers both to normal scarring and also the pathological depositing of excess
connective tissue.
thrombosis - The formation of a thrombus (otherwise known as a blood clot) within a blood
vessel which obstructs the flow of blood.
systole - The contraction of the heart, during which time blood is forced into the aorta and
pulmonary artery.
diastole - The dilatation of the heart after systole in which the chambers of the heart fill
with blood.
hematocrit - The volume percentage of red blood cells in blood.
erythrocytes - The red blood cells.
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CHAPTER 1
INTRODUCTION
Atherosclerosis is the major cardiovascular cause of death in the Western world and is
a major cause of heart attack and stroke [1]. It is characterized by the accumulation of
lipids on the inner layer (intima) of arteries causing inflammation, fibrosis, and hyperplasia
of the endothelium [1, 2]. Atherosclerosis can alter the flow of blood downstream by creating
a stenosis (a narrowing of the arterial opening), by causing the formation of a thrombus
(a blood clot) which is carried downstream to a narrower part of the artery and forms a
blockage there, and by damaging the structural integrity of the vessel wall [1]. Although
this process can occur anywhere throughout the body, this build up of cellular material most
often occurs at bends and branches in the arterial tree [2]. Atherosclerosis does not usually
occur in areas that have high wall shear stress (WSS), but instead prefers areas that have
low average shear stress, secondary flows, or variable shear stress over a cardiac cycle [1].
Percutaneous coronary intervention (PCI) has become the most widely used treatment
for atherosclerosis since its introduction in the late 1970s [3]. PCI involves removing the
blockage by dilating the artery with an angioplasty balloon. Bare metal stents (BMS),
cylindrical mesh-like structures, were developed as an adjunct to PCI for management of
early complications [3]. Although the stents had success in reducing elastic recoil [3], 30-
40% of patients experienced in-stent restenosis (ISR), the condition in which scar tissue
(caused by intimal proliferation) builds and reforms the blockage on top of the stents [3].
Drug-eluting stents (DES) were developed as a solution for ISR and initially showed to be
very effective at reducing ISR [3, 4]. However DES slow the re-endothelialization of the blood
vessel and clinical studies and autopsy findings indicate that although DES may decrease
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early ISR, they inherently increase the risk of late stent thrombosis (LST) and delayed
restenosis [3, 4].
Jukema et al. sought to identify the risk factors which contribute to restenosis [5]. They
identified the inflammatory response to the endothelial injury from the balloon dilation and
the stent placement as playing a key role. Many of the risk factors they cite are either patient-
related (genetic risk factors, the presence of other arterial diseases, or hypersensitivity to
some component of the stent) or lesion-related (due to the length or complexity of the lesion).
Most research in stent design has been focused on material strength, biocompatibility,
flexibility, drug coatings, and improved methods of deployment [6]. However, it has also
been shown that the affect of the strut geometry on the local hemodynamics is such that
it creates an atherosclerosis prone environment, increasing the chances of restenosis and
thrombosis [4, 6]. Thus, it would be advantageous to create a stent design which minimizes
the stent’s affect on local hemodynamics.
The Effect of Geometry on Wall Shear Stress and Blood Flow
Any type of obstacle, whether it be blockage from atherosclerotic plaque or the presence
of a stent, affects the hemodynamics of the blood vessel. Figures 1.1 and 1.2 use the
abbreviation ESS. This stands for endothelial shear stress and is synonymous with wall shear
stress. As illustrated in 1.1B, restenosis disturbs flow in BMS and DES treated arteries in a
similar way as the initial plaque buildup in an atherosclerotic artery [4]. In either case, there
is a region of high WSS and accelerated flow as the blood travels over the obstacle and then
the flow separates from the wall, creating a recirculation zone and a region of low WSS, as
can be seen in Figure 1.1A.
These regions of low and high WSS created by the obstacle affect the particles suspended
in blood in different ways. Although high WSS is typically beneficial in the prevention of
atherosclerosis and restenosis, if the shear rates are too high, it can activate platelets to
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Figure 1.1 Role of Wall Shear Stress in In-Stent Restenosis
[4]
release thromboxane A2 (TXA2) and adenosine diphoshate (ADP), both of which promote
platelet aggregation [6], [4]. These particles pass over the obstacle and become entraped in
the recirculation zone. The low WSS in the recirculation zone suppresses the production of
nitric oxide (NO) and endothelial prostacyclin (PGI2), which are both platelet inhibitors
3
Figure 1.2 The Effect of Strut Geometry on Stent Thrombogenicity
[4]
and anti-coagulants, and tissue plasminogen activator (tPA), a thrombolytic agent. It
also increases production of the coagulation factor von Willebrand Factor (vWF) [6] and
inhibits endothelial cell proliferation, which would normally produce an anti-coagulant
phenotype [4]. Altogether, this creates an environment which favors platelet aggregation and
thrombogenesis. Figure 1.2A illustrates this process in relation to flow over a rectangular
stent strut [4].
Additionally, low WSS up-regulates proinflammatory genes (adhesion molecules, chemoat-
tractant chemokines, and cytokines) which enhances the inflammation response caused
by the injury to the blood vessel [4]. Low WSS also increases production of molecules
which activate smooth muscle cell (SMC) proliferation and migration while it decreases
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production of molecules that inhibit this process (including NO and PGI2). Furthermore,
low WSS also causes these SMCs to shift into synthetic mode and produce more extracellular
matrix molecules [4]. The SMCs and the extracellular matrix molecules are the principal
elements in neointimal hyperplasia (NIH), which is principally responsible for ISR [6]. These
contributions of WSS to ISR are summarized in Figure 1.1C.
Most currently available commercial stents use a rectangular cross-sectional shape. As
can be seen in Figure 1.2A this configuration causes two recirculation zones, a small
recirculation zone at the front of the stent and a larger recirculation zone at the back of the
stent. Jimenez and Davies found that decreasing the width of rectangular cross-sectional
strut decreases the size of the recirculation zone and the area of the endothelium exposed to
recirculation, increasing the probability of endothelialization [6]. Alternatively, the design
of the stent could also be improved by using a more streamlined cross-sectional shape. As
illustrated in Figure 1.2B, the streamlined shape can reduce or even eliminate flow separation
and bring the regions of low WSS and high WSS closer to physiological levels in the vicinity
of the struts [6].
Measurements of WSS
As with many parts of the body, accurate measurements of WSS and shear rate in
living people is difficult to obtain. Katritsis et al. examined the various means currently
available for measuring wall shear stress and shear rate in blood vessels and their results
are summarized in this section. Methods of these measurements fall into 3 categories: in
vitro measurements, in vivo measurements, and computational approximations. In vitro
methods obtain measurements using models of the circulatory system [2]. These models are
often transparent glass tubes with side branches or casts of actual vessels and the methods
for obtaining measurements include flow visualization using dye injection, laser Doppler
anamometry, and particle image velocimetry [7]. Although these methods are useful in
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helping to understand the properties of the fluid itself, they do little to help visualize the
conditions within the body.
In vivo methods obtain measurements directly or indirectly, invasively or non-invasively
in living organisms. Invasive methods use probes placed inside the blood vessel to obtain
measurements of various aspects of the blood flow. These methods all disturb the natural
flow conditions within the vessel and thus actual values of WSS may be different than the
values obtained by these methods [7]. Some examples of invasive techniques include:
• Intravascular Doppler Ultrasound. This method measures flow velocities using
intravascular Doppler wires. A major disadvantage of this technique is that it can
only measure the peak value of velocity and cannot provide information at the wall [7].
If Poiseuille flow is assumed, then the Hagen-Poiseuille formula can be used with this
value of velocity and the diameter of the vessel to obtain an estimate of the WSS.
• Intravascular Ultrasound. In this method, velocity profiles are measured based on
the decorrelation of ultrasonic radio-frequency signals using miniaturized transducer
assemblies inserted into catheters [7]. The shear rate is obtained from the velocity
profile and multiplied by the viscosity to obtain the WSS. The disadvantages to this
method are that it assumes blood to be Newtonian and it cannot be used in the
coronary arteries because there are no probes available that have adequate resolution
to measure velocities there.
Noninvasive methods do not have the inherent flaw which is present in invasive methods.
However, they are often limited by the resolution of the available technology. Noninvasive
methods include:
• Ultrasound. This technique can determine the mean wall shear rate at the anterior
and posterior vessel wall, the time-averaged and peak wall shear rate over one cardiac
cycle, the value at peak systole, and the maximum change in wall shear rate within
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the cardiac cycle [7]. However, the nearest a value can be obtained to the wall is only
250 to 300 µm, wall shear rates can only be reliably determined in relatively straight
vessels, and it cannot be applied to coronary arteries because of overlying bone and
tissue.
• Pulsed Doppler Ultrasound. This technique measures average velocities in a target
volume of a focused acoustic wave [7]. However, the smallest the target volume can be
reduced to is 1 mm3 which does not give an adequate resolution of the velocity profile.
Furthermore, this technique cannot differentiate between the slowly moving vessel wall
and slowly moving blood flowing near the vessel wall. As with the intravascular Doppler
ultrasound, assuming Poiseuille flow, the WSS can be approximated using the velocity
in the center of the vessel and the diameter of the vessel. This method also cannot be
applied to coronary arteries due to the overlying bone and tissue.
• Phase Contrast MRI. Magnetic resonance imaging is capable of examining almost any
vessel in the body, even if there is overlying bone or tissue [7]. Its limitations lie in the
pixelation of the image. A given pixel may be covered partially by moving blood and
partially by the stationary wall, making it difficult to precisely identify the boundary
between the wall and the flow of blood. The spatial resolution is only 0.5-1.0mm, so
measurements of shear rates and shear stress are not precise.
Many of the above in vitro and in vivo methods arrive at estimations for WSS and shear
rate by assuming Poiseuille flow. However, Poiseuille flow makes several assumptions about
the fluid and the nature of the flow [7]:
1. Blood behaves like a Newtonian fluid.
2. The flow is laminar and fully developed. This is valid in most parts of circulation,
but flow can become turbulent in the largest blood vessels or at sites of pathologic
deformations of arterial structure where streamlines may not be parallel to the wall.
7
3. Blood does not slip at the vessel wall. This is held to be universally true for all fluids
(including blood).
4. The flow is steady. In reality, blood flow is pulsatile.
5. The vessel is cylindrical. Most arteries have approximately circular cross-section, but
many veins and the pulmonary arteries tend to be elliptical. Also, the requirement of
constant diameter is never met because individual arteries tend to become narrower as
they progress toward the periphery (veins behave in the reverse way).
6. The vessel wall is rigid. Blood vessels are distensible and their diameter changes with
transmural pressure.
Blood is considered a non-Newtonian fluid because it shows two kinds of shear-dependent
properties: 1) the apparent viscosity increases at low shear rates; and 2) in small vessels,
the apparent viscosity is smaller (at higher shear rates) than it is in larger vessels [1]. The
viscosity of blood is actually dependent on the hematocrit (Hct., a percentage representing
the concentration of erythrocytes), the shear rate, the size of the blood vessel, and blood
temperature [7]. Figure 1.3 shows the viscosity of blood as a function of shear rate for
different Hct [1]. Although the viscosity of blood varies greatly for low shear rates, it is
essentially constant for shear rates > 100s−1. Therefore, the assumption that blood is a
Newtonian fluid is valid in medium and large arteries only for rates of shear > 100s−1 [7].
The final method of obtaining measurements of WSS and shear rate is through
computational fluid dynamics (CFD) simulations. According to Katritsis et al., the
limitations of CFD when applied to blood flow come from defining the problem, rather than
from the accuracy of the numerical model [7]. Many of the assumptions made concerning
Poiseuille flow are also made in CFD simulations to simplify the problem. Comparison of
results obtained from steady-state Newtonian and non-Newtonian models revealed that the
distribution pattern of WSS is similar, but that the magnitude of the estimate depends on
8
Figure 1.3 Blood Viscosity for Different Hct.
[1]
the model used [7]. Furthermore, in comparing the Newtonian and non-Newtonian models
for pulsatile flow, it was observed that the Newtonian models yielded lower WSS values
throughout the entire cardiac cycle, but that the distribution pattern of WSS was again
similar. Thus the Newtonian assumption is an adequate approximation of the distribution
pattern for WSS, but not necessarily for the magnitude. The most important limitation,
however, is that there is no accepted standard against which any of these methods can be
verified and that all methods of WSS measurement produce at best only approximations to
the actual WSS values.
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CHAPTER 2
APPROACH
The goal of this study is to use numerical methods to solve the compressible Navier-Stokes
equations and determine values for WSS and shear rate and to then use a commercially
available optimization software to find a design which will maximize shear rate (and thus
WSS) in the vicinity of the stent. The components required to accomplish this are an
optimization problem which can be phrased as a minimization problem and the optimizer.
The optimizer requires a way to change the mesh according to new design variables (the
mesh movement routine) and a way to evaluate the cost function (the flow solver). The
optimization software chosen for this study was Dakota and it further requires that the
mesh movement and the flow solver be linked together by a driver script, which it calls
whenever it requires a function evaluation.
Optimization
Dakota (Design Analysis Kit for Optimization and Terascale Applications) contains
algorithms to solve minimization problems using gradient or non-gradient based methods
[8]. In addition to specifying the optimization method, design variables, tolerances, etc., the
user also needs to provide Dakota with a means of obtaining evaluations of the cost function
(and, if applicable, the derivatives of the cost function). This is typically done through a
script which translates requests from Dakota into input for the program evaluating the cost
(such as a flow solver) and then translates the output from this program back into the format
Dakota requires. A simplified outline of this process is provided in Figure 2.1.
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Read in user specified input 
(method, strategy, interface, 
tolerance, …).
Generate 1 or more initial 
guesses if not specified by user.
Evaluate the guess(es) using the 
specified interface.
Has the specified tolerance or 
maximum number of iterations 
been me?
Generate new guess(es) based 
on specified method.
Return the best solution to the 
user.
No
Yes
Figure 2.1 Illustration of Dakota’s Optimization Process
A python script was used in this study to interface between Dakota and the flow solver.
In this implementation, the design variables were the coefficients of the basis functions used
to parametrize the shape of the stent (this is explained later in this chapter). In this case
the application of the design variables involves moving the boundary of the mesh to a new
location and smoothing the interior points. After the mesh is moved, the script makes a
system call to the flow solver and then translates the output into a format that Dakota can
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understand. Figure 2.2 illustriates the actions performed by the driving script. Also, note
that the driving script is the “specified interface” mentioned in Figure 2.1. For an example
of the Dakota input file used in this study, refer to appendix A.
Read in the new values for the 
design variables from Dakota.
Apply the design variables.
Evaluate the cost function (and 
possibly the derivatives).
Return the cost (and 
derivatives) to Dakota.
Figure 2.2 Illustration of the Steps Performed by the Driver Script
Evolutionary Algorithms
Dakota’s evolutionary algorithm, coliny ea, was the chosen method for optimization
in this study. Evolutionary algorithms (EAs) are global optimization methods which
12
are suitable for solving problems that have multiple local optima and problems in which
gradients are not available or are expensive to compute [9]. These methods are based
on Darwin’s theory of survival of the fittest and the process is illustrated in Figure 2.3.
The EA treats design points as members of a population and the design parameters as
DNA. The algorithm starts with a randomly selected population of design points within
the parameter space. Through a sequence of generations, members of the population are
ranked based on their objective function evaluation (with low objective function values being
considered the most “fit”) and only the fittest are allowed to survive and reproduce [9]. The
EA simulates evolution through mathematical analogs of natural selection, breeding, and
mutation, ultimately identifying a design point (or a family of design points) that minimize
the objective function [9].
Figure 2.3 Illustration of the Evolutionary Algorithm
[8]
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Cost Function
It has been shown that low shear rates are a contributing factor to the development
of restenosis and that blood behaves like a Newtonian fluid for shear rates > 100. Thus
a design is sought which not only maximizes the wall shear rate but also ensures that the
value everywhere along the wall is > 100. However, DAKOTA is set up to solve minimization
problems, so this maximization problem needs to be reprhased as a minimization problem.
Equation 2.1 shows the proposed cost function for minimization based on shear rate.
Cost =
∑ 1
(S∗)2
(2.1)
where the summation is over all points on the wall within an appropriate region of the stent
and S∗ is the local non-dimensional shear rate. Dimensional shear rate is given by
S = 2
√
S212 +
1
2
(S211 + S
2
22) (2.2)
S12 =
1
2
(
∂u
∂y
+
∂v
∂x
)
(2.3)
S11 =
∂u
∂x
(2.4)
S22 =
∂v
∂y
(2.5)
Following the nondimensionalization provided later in this text for the flow solver, a
nondimensional shear rate can be found using
S∗12 =
1
2
(
∂u∗
∂y∗
+
∂v∗
∂y∗
)
(2.6)
S∗11 =
∂u∗
∂x∗
(2.7)
S∗22 =
∂v∗
∂y∗
(2.8)
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where the nondimensional terms are related to the dimensional terms by
S12 = S
∗
12
V∞
L
(2.9)
S11 = S
∗
11
V∞
L
(2.10)
S22 = S
∗
22
V∞
L
(2.11)
Substituting Equations 2.9 - 2.11 into Equation 2.2 we find
S =
V∞
L
S∗ (2.12)
for the bloodflow cases, V∞ = 0.2228 and L = 0.004. Thus for dimensional shear rate
S = 100s −1, the corresponding nondimensional shear rate is S∗ ≈ 1.79.
Notice that in the cost function provided in Equation 2.1, if S∗ >> 1 the contritubtion
to the summation is essentially zero whereas if S∗ << 1 the cost will be very high. In reality,
a valid shear distribution may have values near to 1.79 which means that designing to this
cost function cannot actually achieve a cost of zero. This actually relaxes the convergence
requirements and allows values on the order of 1.0e+00 and even 1.0e+01 to be considered
ideal. Furthermore, this function considers the entire distribution of shear rates. This is
important because, as stated in Chapter 1, the Newtonian assumption made by many flow
solvers is adequate only in the obtaining the shear distribution and not in obtaining the
actual values of shear.
Obviously, the situation which truly maximizes the shear rate is to have no stent at all
obstructing the flow. Since this is not an option, a side constraint needs to be defined to
ensure that the stent has width. Since the shape of the stent is defined by a set of points,
it is easy to approximately compute the area of the stent. The side constraint used in this
study is defined in equation 2.13 and ensures that the area of the new stent cross-sectional
shape must be greater than half the area of the commercially used square cross-sectional
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stent wires.
A > 0.00000001 mm2 (2.13)
Governing Equations
The two-dimensional Navier-Stokes equations (provided in full in [10]) are presented
below neglecting body forces and external heat:
∂ρ
∂t
+∇ · (ρV ) = 0 (2.14)
∂
∂t
(ρV ) +∇ · ρV V −∇ ·Πij = 0 (2.15)
∂Et
∂t
+∇ · EtV +∇ · q −∇ · (Πij · V ) = 0 (2.16)
where ∇ is the divergence operator, V is the velocity vector, ρ is the density, Et is the total
energy per unit volume, q = −k∇T is the heat transfer (T is the temperature and k is the
coefficient of thermal conductivity), and the stress tensor is represented by Πij. In the above
equations,
Et = ρ
(
e+
u2 + v2
2
)
(2.17)
Πij = −pδij + τij (2.18)
τij = µ
[(
∂ui
∂xj
+
∂uj
∂xi
)
− 2
3
δij
∂uk
∂xk
]
(2.19)
where e is the internal energy per unit mass, u and v are the x and y components of velocity,
p is the pressure, δij is the Kroenecker delta function, and µ is the coefficient of viscosity.
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The implementation uses the following nondimensionalization [10]:
x∗ = x
L
y∗ = y
L
t∗ = tL
V∞
u∗ = u
V∞ v =
v
V∞ µ
∗ = µ
µ∞
ρ∗ = ρ
ρ∞ p
∗ = p
ρ∞V 2∞
T ∗ = T
T∞ e
∗ = e
V 2∞
(2.20)
where L is the reference length, the subscript ∞ represents freestream conditions, and the
Reynolds number is given by ReL =
ρ∞V∞L
µ∞ . Substituting these nondimensionalized variables
back into equations 2.14 - 2.16 and rewriting in vector form gives:
∂Q∗
∂t∗
+
∂f ∗i
∂x∗
+
∂g∗i
∂y∗
=
∂f ∗v
∂x∗
+
∂g∗v
∂y∗
(2.21)
where Q is the vector of conservative variables given by
Q∗ =

ρ∗
ρ∗u∗
ρ∗v∗
E∗t

(2.22)
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fi and gi are the inviscid fluxes given by
f ∗i =

ρ∗u∗
ρ∗u∗2 + p∗
ρ∗u∗v∗
(E∗t + p
∗)u∗

(2.23)
g∗i =

ρ∗v∗
ρ∗u∗v∗
ρ∗v2∗ + p∗
(E∗t + p
∗)v∗

(2.24)
and fv and gv are the viscous fluxes given by
f ∗v =

0
τ ∗xx
τ ∗xy
u∗τ ∗xx + v
∗τ ∗xy − q∗x

(2.25)
g∗v =

0
τ ∗xy
τ ∗yy
u∗τ ∗xy + v
∗τ ∗yy − q∗y

(2.26)
τ ∗xx =
2µ∗
3ReL
(
2
∂u∗
∂x∗
− ∂v
∗
∂y∗
)
(2.27)
τ ∗yy =
2µ∗
3ReL
(
2
∂v∗
∂y∗
− ∂u
∗
∂x∗
)
(2.28)
τ ∗xy =
µ∗
ReL
(
∂u∗
∂y∗
+
∂v∗
∂x∗
)
(2.29)
q∗x = −
µ∗
(γ − 1)M2∞ReLPr
∂T ∗
∂x∗
(2.30)
q∗y = −
µ∗
(γ − 1)M2∞ReLPr
∂T ∗
∂y∗
(2.31)
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The Mach number and the nondimensionalized forms of the equations of state are given by:
M∞ =
V∞√
γRT∞
(2.32)
p∗ = (γ − 1)ρ∗e∗ (2.33)
T ∗ =
γM2∞p
∗
ρ∗
(2.34)
where R is the gas constant and γ is the ratio of specific heats.
Numerical Formulation
The nondimesionalized compressible Navier-Stokes equations given by 2.21 are discretized
in a point Gauss-Siedel implicit node-centered finite volume scheme which is 2nd order
accurate in space, 1st order accurate in time. The scheme uses Van Leer flux vector splitting
for the inviscid fluxes, central differencing for the viscous fluxes, and characteristic variable
boundary conditions. The discretized equation for the ith node is:
Ai
∆Qi
∆ti
+
∑
j
∂Fi
∂Qj
∆Qj = −
∑
j
Fij · nˆij +
∑
j
Fvij · nˆij (2.35)
where ∆Q is the change in Q for node i between the n and n+ 1 timesteps, ∆ti is the local
timestep for node i, ∂Fi
∂Qj
are derivatives of the inviscid flux at node i with respect to Q, Fij
and Fvij are the inviscid and viscous fluxes across the face between nodes i and j, and nˆij is
the unit vector normal to the control volume face between nodes i and j. In two dimensions,
Ai is the area of the control volume around node i and Sij is the length of the vector that
forms the face between nodes i and j.
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Timestep Calculation
The local timestep for node i is taken to be the area of the control volume around i
divided by the sum over all edges around i of the largest eigenvalue:
∆ti =
Ai∑
j(|U¯ |+ c)l
(2.36)
where U¯ = unˆx + vnˆy is the contravariant velocity, c is the local speed of sound, and l is the
length of the vector n, which is normal to the face between i and j.
Van Leer Flux Vector Splitting
The inviscid flux in equation 2.35 is computed using Van Leer flux vector splitting. The
flux is split into two components, F+ and F− such that the following criteria are satisfied
[10]:
1. F (Q) = F+(Q) + F−(Q).
2. ∂F
+
∂Q
contains all eigenvalues ≥ 0 and ∂F−
∂Q
contains all eigenvalues ≤ 0.
3. F± must be continuous with F+(Q) = F (Q) for U¯ ≥ c and U¯
c
≥ 1 and F−(Q) = F (Q)
for U¯ ≤ −c and U¯
c
≤ −1
4. The components of F+, F− exhibit the same symmetry that F exhibits (if F (U¯) =
±F (−U¯), then F+ = ±F−(−U¯)).
5. The Jacobians ∂F
±
∂Q
are continuous.
6. The Jacobians ∂F
±
∂Q
must have one eigenvalue vanish for |M | < 1.
7. F± must be a polynomial in Mach number of lowest possible order.
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The equations for Van Leer flux vector splitting are given below [11].
F± =

±1
4
ρc
(
U¯
c
± 1
)2
F±1
(
nˆx
γ
(−U¯ ± 2c)+ u)
F±1
(
nˆy
γ
(−U¯ ± 2c)+ v)
F±1
[
−(γ−1)U¯2±2(γ−1)U¯c+2c2
γ2−1 +
u2+v2
2
]

(2.37)
where U¯ is the contravariant velocity U¯ = unˆx+vnˆy and c is the local speed of sound. Thus,
for a given face between nodes i and j, the inviscid flux is
Fij · nˆij = F+(Ql) + F−(Qr) (2.38)
Ql and Qr are the Q values on the left and right, respectively, and are determined by the
direction of the normal. For instance, for first order spatial accuracy when nˆ points in
the direction from node i to node j, Ql = Qi and Qr = Qj. For second order spatial
accuracy, the gradients at the nodes are involved, resulting in Ql = Qi +∇Qi · (~xm−~xi) and
Qr = Qj +∇Qj · (~xm − ~xj), where ~xi, ~xj are the coordinate vectors associated with nodes
i and j respectively and ~xm is the coordinate vector of the midpoint of the edge between i
and j.
Boundary Conditions
The computation of the fluxes requires information on the left and the right side of the
face between the nodes. These left and right states are easy to identify inside the mesh,
but this is difficult at the boundaries. For flux computation on a given boundary segment,
Ql is taken to be an average of the Q values at the boundary nodes and Qr is taken to
be the Q values at some “ghost” node just outside the boundary. Characteristic variable
boundary conditions are used in this implementation to find the appropriate Q values for
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this ghost node. Bloodflow is characterized by very low Mach numbers, so the boundary
conditions needed for the cases are: subsonic inflow, subsonic outflow, impermeable surface,
and symmetry plane. In the following discussion of boundary conditions, variables with a
subscript i refer to values at physical nodes, variables with the subscript ∞ refer to the values
at freestream, the subscript b refers to the value at the ghost node, and the subscript 0 refers
to an arithmetic average of the values at the physical and ghost nodes. The convention
used in this implementation is for outward pointing boundary normals. The eigenvalues are
λ1 = λ2 = θ, λ3 = θ+c, and λ4 = θ−c, where θ is the contravariant velocity: θ = unˆx+vnˆy.
Subsonic Inflow
Subsonic inflow is characterized by λ1,2,4 < 0 and λ3 > 0. Following the derivation in
[12], the boundary values are given by the following equations:
pb =
1
2
[p∞ + pi − ρ0c0 {nˆx(u∞ − ui) + nˆy(v∞ − vi)}] (2.39)
ρb = ρ∞ − p∞ − pb
c20
(2.40)
ub = u∞ − nˆxp∞ − pb
ρ0c0
(2.41)
vb = v∞ − nˆy p∞ − pb
ρ0c0
(2.42)
Subsonic Outflow
Subsonic outflow is characterized by λ1,2,3 > 0 and λ4 < 0. Following the derivation in
[12], which takes pressure to be the one piece of information that comes from outside the
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domain, the boundary values can be given by the following equations:
pb = p∞ (2.43)
ρb = ρi +
pb − pi
c20
(2.44)
ub = ui − nˆxpb − pi
ρ0c0
(2.45)
vb = vi − nˆy pb − pi
ρ0c0
(2.46)
For internal flow problems p∞ refers to a specified back pressure which preserves the desired
pressure drop across the domain. In all other cases, it refers to the pressure at the freestream
conditions.
Solid Wall Conditions
An inviscid solid wall is characterized by λ1,2 = 0, λ3 > 0 and λ4 < 0. This condition is
also called a “slip” condition because it allows flow tangential to the boundary but does not
allow any flow through the boundary. The resulting equation set is:
pb = pi + ρ0c0 (nˆxui + nˆyvi) (2.47)
ρb = ρi +
pb − pi
c20
(2.48)
ub = ui − nˆxpb − pi
ρ0c0
(2.49)
vb = vi − nˆy pb − pi
ρ0c0
(2.50)
The viscous solid wall condition (also called a “no-slip” condition) is computed in the
same way as the inviscid solid wall condition except that u and v are identically zero at the
boundary.
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Symmetry Plane
A symmetry plane condition is used in cases where the flow is assumed to be symmetric
about a plane and thus the problem size can be reduced in half. All of the meshes created
with this condition are completely structured, so every symmetry plane node is connected
to exactly one non-symmetry plane node. Let the subscript i here refer to the values at this
non-symmetry node. Then the values at the boundary are given by:
pb = pi (2.51)
ρb = ρi (2.52)
ub = Vi − (Vi · nˆ) nˆx (2.53)
vb = Vi − (Vi · nˆ) nˆy (2.54)
Mesh Movement
In order to optimize the cross-sectional shape of the stent, two operations need to be
performed on the mesh:
1. To reduce the total number of design variables, the boundary representing the stent
needs to be parametrized.
2. Based on the above parametrization, the mesh needs to be moved to the new stent
shape proposed by the optimizer.
This implementation uses Hick-Henne functions for parametrization and linear elastic
smoothing for the mesh movement.
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Hicks-Henne Parametrization
The Hicks-Henne shape functions are a set of n sine waves with specified positions for
the maximum of each wave in the interval (0, 1) [13]. Let xMi be the specified location for
the maximum of the ith function and let its position be defined in the following way:
xMi = 0.5 (1− cos(θi)) (2.55)
where θi =
pii
n+1
. This produces a distribution of xMi ’s that is denser towards the leading and
trailing edges. The Hicks-Henne functions are then defined by:
bi(x) = sin
4(pixmi) (2.56)
mi =
ln 0.5
lnxMi
(2.57)
(2.58)
Any new shape for the boundary can be obtained by adding a linear combination of the
n Hicks-Henne functions to the initial shape. In this case the n weights of the linear
combination become the n design variables that the optimization routine will find. As can
be seen in figure 2.4, although the distribution of the xMis is symmetric over the interval,
the resulting functions are not symmetric. For instance, the peak for the first and last
function is the same distance from the boundary of the interval, however the sine wave
for the first function has a greater width than the sine wave for the last function. This
type of parametrization favors an airfoil-like shape. It is also important to note that this
parametrization is based on the initial mesh and requires that every function evaluation for
the design process start from the exact same mesh.
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Figure 2.4 Hicks-Henne Shape Functions for 16 Design Variables
Linear Elastic Smoothing
Linear-elastic smoothing is a robust method of mesh movement which smoothes the
interior points of a mesh when the boundary has been moved or deformed [14]. Linear-
elastic smoothing can perform very large deformations in both viscous and inviscid meshes
while maintaining good spacings in the boundary layer. This method is ideal for design
optimization since it can handle large deformations of the mesh and it can also be used to
find mesh sensitivity derivatives for gradient-based optimization methods[14].
The differential equations governing linear-elastic smoothing in two dimensions are
presented below [14].
∂
∂x
[
α1
∂u
∂x
]
+
∂
∂y
[
α2
∂u
∂y
]
+
∂
∂x
[
α3
∂v
∂y
]
+
∂
∂y
[
α2
∂v
∂x
]
= 0 (2.59)
∂
∂x
[
α2
∂v
∂x
]
+
∂
∂y
[
α1
∂v
∂y
]
+
∂
∂x
[
α2
∂u
∂y
]
+
∂
∂y
[
α3
∂u
∂x
]
= 0 (2.60)
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where
α1 =
E(1− ν)
(1 + ν)(1− 2ν) (2.61)
α2 =
E
2(1 + ν)
(2.62)
α3 =
Eν
(1 + ν)(1− 2ν) (2.63)
(2.64)
In the above equations, the solution vector [u, v]ᵀ defines the displacement at each node [14],
E represents Young’s Modulus and is taken to be the element aspect ratio, and ν represents
Poisson’s ratio and is taken to be 0.20. The resulting system of equations is solved using a
point implicit finite volume method.
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CHAPTER 3
VALIDATION
The goal of this section is to show that the solver matches benchmark analytical solutions
for viscous flow and that it matches published computational results for blood flow. The
viscous terms and boundary conditions will be verified by examining the Blasius equation
for laminar flow over a flat plate and Couette flow. The blood flow cases will consider flow
through a stented artery for a square, semi-circular, and streamlined shaped stent cross-
section.
Laminar Flow Along a Flat Plate
The first validation case considered is laminar flow along an infinitely thin flat plate. This
case was chosen because the nature of the flow is characterized by the viscous terms and so it
will verify that the code can simulate viscous flow. The Blasius equation, shown in equation
3.1, takes the boundary-layer equations (2 partial differential equations) and combines them
through the dimensionless coordinate η into one ordinary differential equation [15].
f(η)f ′′(η) + 2f ′′′(η) = 0 (3.1)
η = y
√
U∞
νx
(3.2)
Furthermore, the velocity profile can be obtained from the relation
u
U∞
= f ′(η) (3.3)
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A structured mesh with viscous spacing was created which is rectangular in shape. The
sides and top have a farfield condition and the bottom of the plate is split into 3 sections: a
flat plate of unity length and viscous wall condition with a region of inviscid wall conditon
on either side. A Reynold’s number of 10000, Mach number of 0.8, and normal freestream
conditions for air were used for this case.
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Figure 3.1 Comparison of Profiles for Blasius Test Case
Figure 3.1 shows the comparison of the computed solution to the analytical solution of
the Blasius equation. The analytical solution used is the numerical solution to the Blasius
equation found by L. Howarth [15]. The computed solution is found using the velocities in a
column of the mesh located at 3
4
of the length of the plate. The computed solution reaches
a value slightly higher than 1 at freestream. This can be attributed to the fact that the
abrupt transition between the inviscid wall condition and the viscous wall condition at the
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leading edge of the plate causes the velocity to speed up slightly. Other than this overshoot,
the computed solution agrees well with the analytical solution.
Couette Flow
The second validation case is Couette flow, which is flow between two parallel surfaces in
which the distance h between the surfaces is small in comparison to the length of the channel.
This case was chosen because it is the two-dimensional analog of Poiseuille flow, which is
often used to model the flow of blood in blood vessels. Couette flow is not only viscous
dominated, but also highly dependent on the boundary conditions. Successful execution of
this case will verify that the boundary conditions and the freestream conditions are adequate
for modeling blood flow problems.
In Couette flow, the direction of flow is in the x-direction only, causing pressure to become
a function of x only and velocity to become a function of y only [16]. The Navier Stokes
equations then reduce to:
0 = −dp
dx
+ µ
d2u
dy2
(3.4)
Integrating this twice and applying the conditions u(0) = u(h) = 0, the velocity can
expressed as a function of y:
u(y) = − 1
2µ
dp
dx
y (h− y) (3.5)
Dividing by a reference velocity and substituting P = − h2
2µU
dp
dx
produces the nondimension-
alized velocity profile:
u(y)
U
= P
y
h
(
1− y
h
)
(3.6)
Thus when the pressure drop through the channel, h, and µ are known, the velocity profile
can be exactly computed using the above equation.
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The freestream conditions for the blood flow cases were derived from the density and
viscosity of blood (assumed to be constant) using Couette flow and the equations of state.
They are listed in Table 3.1.
Table 3.1 Freestream Conditions for Blood Flow Cases
Variable Value Unit of Measure
Density 1060·0 kg/m3
Viscosity 0·0035 kg/m·s
Reference Length 0·004 m
Temp 0·0442482 degree K
Velocity 0·2228773585 m/s
Inlet Pressure 13463·89 Pa
Back Pressure 13424·808455 Pa
Mach Number 0·052853 (dimensionless)
Reynolds Number 270·0 (dimensionless)
Three structured meshes were created for this test case with 32×32, 64×64, and 128×128
evenly spaced points. Each mesh extends from −50 mm to 50.2 mm in the x-direction and
from 0 to a height of 4 mm in the y-direction. The profiles for the computed solutions were
taken at the center column in the mesh. Figure 3.2 compares the velocity profiles from the
computed solutions to the analytical profile.
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Figure 3.2 Comparison of Velocity Profiles for Couette Flow:Full Profile
Since Couette flow is naturally symmetric about the centerline of the channel, the problem
can be cut in half using a symmetry condition. Three structured meshes were created which
again extended from −50 to 50.2 mm in the x-direction but only extended from 0 to 2 mm
in the y-direction. These three meshes had the same spacings as those before, but only half
the total number of points. Figure 3.3 shows the comparison of the computed solutions to
that of the analytical solution found for the same flow conditions. In both cases, as the mesh
is refined, the computed solution more closely matches the analytical solution.
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Figure 3.3 Comparison of Velocity Profiles for Couette Flow: Symmetry Plane Condition
It is worth noting that the reference velocity U for the analytical profile was taken to be
the freestream velocity whereas for the computed solutions it was taken to be the maximum
velocity in the mesh at the column of x values. The reason for this discrepancy is that
the characteristic inflow condition is not the ideal boundary condition for this type of flow.
While the appropriate pressure is achieved at the outflow, the inflow pressure is not exactly
matched. A total pressure condition for the inflow boundary would help enforce the correct
pressure drop and implementing such a condition is intended for the future.
Stent Validation Cases
This section compares the results of simulating flow thorugh stented blood vessels to
results from other studies. Three geometries are considered: rectangular, semi-circular, and
streamlined stent cross-sectional shapes. The parameters for the geometries are those used
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by Chen et al., in which the height h of each stent is 0.1 mm, the width d of the rectangular
and semi-circular stents is 0.2 mm and the width of the streamlined stent is 0.5 mm, and the
diameter of the blood vessel is 4.0 mm [17]. The shape of the streamlined stent is defined
by the equation:
R(z) = 0.1e−z
2
(3.7)
where z = d/h (−2.5 ≤ z ≤ 2.5). Jimenez and Davies also studied the rectangular and
semi-circular shapes using one stent ring, whereas Chen et al. used five stent rings. In order
to compare to both studies, the meshes were created with only one stent ring. The viscous
spacing used is small enough to resolve the recirculation zones. The contours of the velocity
for each of the shapes can be seen in Figures 3.4 - 3.6.
Chen et al. compared the length of the recirculation zone to the height of the stent for
each of their 5 stent rings. Their results can be found in Figure 3.7, in which P1-P5 represent
the positions of the 5 stent rings and L
h
represents the ratio of recirculation length to stent
height. Jimenez and Davies also studied the rectangular and semi-circular stents and found
L
h
for the case of one stent ring to be approximately 0.845 for the rectangular stent and 0.47
for the semi-circular stent. The results obtained here consider the case of only one stent
ring and L
h
was found to be approximately 0.8 for the rectangular stent and 0.48 for the
semi-circular stent. These values correspond well with the results of first stent right of the
Chen study as well as to the values found by Jimenez and Davies. The streamlined stent
had no observable recirculation, which also corresponds well to the results of L
h
< 0.0015
obtained by Chen et al.
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Figure 3.4 Contours of Velocity for the Rectangular Stent
Figure 3.5 Contours of Velocity for the Semi-Circular Stent
Figure 3.6 Contours of Velocity for the Streamlined Stent
35
Figure 3.7 Effect of Cross-Sectional Shape on the Length of Recirculation Zones
Jimenez and Davies also studied the profiles of WSS and shear rate for the rectangular
and semi-circular stents with varying aspect ratios. Their results can be seen in Figure 3.8,
in which part (a) shows the results for the rectangular stent, part (b) shows the results for
the semi-circular stent, and the dashed line in each section corresponds to the 2:1 aspect
ratio studied here. Figures 3.9 and 3.10 show the distribution of shear rate in the vicinity of
the rectangular and semi-circular stents obtained from the computed results. The profile for
the rectangular stent matches very well with the results obtained by Jimenez and Davies.
The profile for the semi-circular stent achieved a shape similar to the profile obtained by
Jimenez and Davies, however the values do not match. This can be attributed to the fact
that Jimenez and Davies are using a blood vessel that is 3 mm in diameter and 19.2 mm in
length, which may not be long enough to sufficiently establish the inlet velocity profile. Also,
they do not provide much detail as to the resolution of their meshes and since this shape is
naturally more streamlined than the rectangle, there may not be sufficient resolution for the
shear profile to fully develop.
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Figure 3.8 WSS and Shear Rate Distributions Obtained by Jimenez and Davies for
Rectangular and Semi-Circular Stent Shapes
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Figure 3.9 Computed WSS Distribution for Rectangular Stent Shape
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Figure 3.10 Computed WSS Distribution for Semi-Circle Stent Shape
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CHAPTER 4
RESULTS
The Hicks-Henne parametrization changes the shape of an existing mesh to obtain the
new desired shape. Four different initial shapes were chosen to examine the dependency of
the final optimized shape on the initial shape: an elliptical shape, the exponential shape
defined by equation 3.7, an airfoil shape, and a flat plate. It is important to note that since
the new shape depends on the distribution of the initial mesh, it is possible (and in fact
probable) that the optimizer will request a set of design variables which produces a bad
mesh. In such a case, the solver will return a cost of 1.0e+15, which is orders of magnitude
higher than the cost for any valid mesh. The results in this chapter show only the valid
meshes created in the design process.
The initial meshes created have viscous spacing small enough to resolve the recirculation
zones and the points on the stent are clustered towards the front and back of the stent. The
mesh for the exponential shaped stent can be seen in Figure 3.6. Figures 4.1, 4.2, and 4.3
show the meshes for the elliptical, airfoil, and flat initial stent shapes respectively.
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Figure 4.1 Contours of Velocity for Elliptical Shaped Stent
Figure 4.2 Contours of Velocity for Airfoil Shaped Stent
Figure 4.3 Contours of Velocity for Flat Stent
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Design of the Elliptical Shaped Stent
The elliptical shape was chosen because it is in a middle position between the ideal
unstented case and the extreme semi-circle case. The design process was performed using
8, 12, and 15 design variables as a convergence study and to observe the effect of an even
versus an odd number of design variables on the resulting shape.
8 Design Variables
Figures 4.4 - 4.8 show the first 5 valid meshes created in the design process using the
elliptical shaped stent and 8 design variables. These images show variations of 2 distinct
shapes.
Figure 4.4 Elliptical Shape Design With 8 Design Variables: Iteration 5
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Figure 4.5 Elliptical Shape Design With 8 Design Variables: Iteration 7
Figure 4.6 Elliptical Shape Design With 8 Design Variables: Iteration 17
Figure 4.7 Elliptical Shape Design With 8 Design Variables: Iteration 19
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Figure 4.8 Elliptical Shape Design With 8 Design Variables: Iteration 22
Figures 4.9 - 4.11 show the final 3 meshes produced in the design process. These images
show that Dakota is optimizing toward the shape initially identified by 5th function evaluation
(shown in Figure 4.4). This shape has a region of very high velocity on the back side of the
stent and also has a very large recirculation zone behind the stent.
Figure 4.9 Elliptical Shape Design With 8 Design Variables: Iteration 203
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Figure 4.10 Elliptical Shape Design With 8 Design Variables: Iteration 205
Figure 4.11 Elliptical Shape Design With 8 Design Variables: Iteration 206
Figure 4.12 shows the evaluations of the cost function for each set of valid design variables
requested by Dakota and Figure 4.13 shows the corresponding areas for each of the cost
evaluations. Although the cost is chatotic at first, Dakota begins to identify a family of
configurations which produce a significantly lower cost. Unfortunately, the area constraint
of 1.0e-08 is never met and the cost for the more optimized shapes is still in the 1000s,
indicating that the strain rate is not > 100s−1 everywhere.
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Figure 4.12 Convergence of Design of the Elliptical Stent Using 8 Design Variables
 5.5e-09
 6e-09
 6.5e-09
 7e-09
 7.5e-09
 8e-09
 8.5e-09
 9e-09
 9.5e-09
 1e-08
 0  50  100  150  200  250
Are
a
Function Evaluation
Figure 4.13 Area of Designs of the Elliptical Stent Using 8 Design Variables
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12 Design Variables
Figures 4.14 - 4.18 show the first 5 valid meshes produced in the design process using
the elliptical starting shape and 12 design variables. Just as with the 8 design variable case,
these images show variations on 2 distinct shapes.
Figure 4.14 Elliptical Shape Design With 12 Design Variables: Iteration 18
Figure 4.15 Elliptical Shape Design With 12 Design Variables: Iteration 28
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Figure 4.16 Elliptical Shape Design With 12 Design Variables: Iteration 32
Figure 4.17 Elliptical Shape Design With 12 Design Variables: Iteration 40
Figure 4.18 Elliptical Shape Design With 12 Design Variables: Iteration 49
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Figures 4.19 - 4.21 show the final 3 meshes of the design process. These images indicate
that Dakota is designing towards a symmetric shape. This shape is very different from the
final shape in the 8 design variable case and does not have a region of high velocity along
the back of the stent. Also the recirculation zone behind the stent is smaller than it was in
8 design variable case.
Figure 4.19 Elliptical Shape Design With 12 Design Variables: Iteration 194
Figure 4.20 Elliptical Shape Design With 12 Design Variables: Iteration 195
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Figure 4.21 Elliptical Shape Design With 12 Design Variables: Iteration 197
Figure 4.22 shows the convergence of the design process using 12 design variables and
the initial elliptical shape. The corresponding areas are shown in Figure 4.23. This case was
able to more quickly identify a family of optimal configurations, but the cost is still very
high. The areas observed are slightly higher than for the case with 8 design variables, but
they still do not meet the constraint.
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Figure 4.22 Convergence of Design of the Elliptical Stent Using 12 Design Variables
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Figure 4.23 Area of the Designs of the Elliptical Stent Using 12 Design Variables
15 Design Variables
Figures 4.24 - 4.28 show the first 5 valid meshes produced in the design process using
the elliptical starting shape and 15 design variables. Unlike the case for 8 and 12 design
variables, these images show only variations on one distinct shape.
Figure 4.24 Elliptical Shape Design With 15 Design Variables: Iteration 8
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Figure 4.25 Elliptical Shape Design With 15 Design Variables: Iteration 11
Figure 4.26 Elliptical Shape Design With 15 Design Variables: Iteration 17
Figure 4.27 Elliptical Shape Design With 15 Design Variables: Iteration 20
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Figure 4.28 Elliptical Shape Design With 15 Design Variables: Iteration 21
Figures 4.29 - 4.31 show the final 3 meshes produced in the design process. Again, the
design process converged to a completely different shape than that observed in either the 8
or 12 design variable cases. This shape has a region of high velocity along the back of the
stent, just as with the 8 design variable case, and the recirculation zone behind the stent has
not been improved.
Figure 4.29 Elliptical Shape Design With 15 Design Variables: Iteration 197
51
Figure 4.30 Elliptical Shape Design With 15 Design Variables: Iteration 198
Figure 4.31 Elliptical Shape Design With 15 Design Variables: Iteration 200
Figure 4.32 shows the convergence of the cost for designing the elliptical stent with 15
design variables and the corresponding areas can be seen in Figure 4.33. This case produced
significantly lower costs than either the 8 or 12 design variable cases, however the area
constraint was still not met.
52
 0
 500
 1000
 1500
 2000
 2500
 0  20  40  60  80  100  120  140  160  180  200
Co
st
Function Evaluation
Figure 4.32 Convergence of Design of the Elliptical Stent Using 15 Design Variables
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Figure 4.33 Area of Designs of the Elliptical Stent Using 15 Design Variables
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Design of the Exponential Shaped Stent
The exponential shape was considered for design since it was proposed as a streamlined
stent by Chen et al. [17]. This case was performed using 12 design variables. Figures 4.34
- 4.38 show the first 5 valid meshes produced in the design process. Four of these shapes
still resemble the initial exponential shape. It is interesting to note that several of these
shapes dip below the level of the blood vessel wall towards the back of the stent. In reality,
a portion of the stent’s thickness sinks into the wall of the blood vessel. Thus, a slight dip
below the level of the blood vessel may be producible.
Figure 4.34 Exponential Shape Design With 12 Design Variables: Iteration 2
Figure 4.35 Exponential Shape Design With 12 Design Variables: Iteration 3
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Figure 4.36 Exponential Shape Design With 12 Design Variables: Iteration 7
Figure 4.37 Exponential Shape Design With 12 Design Variables: Iteration 8
Figure 4.38 Exponential Shape Design With 12 Design Variables: Iteration 9
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Figures 4.39 - 4.41 show the final 3 valid meshes produced in the design process. Dakota
seems to be designing toward an elliptical-like shape with a lower peak, which has a portion
that extends below the level of the blood vessel wall. This shape is very different than any
of the shapes obtained using the initial elliptical shape and the recirculation zone behind the
stent is nearly eliminated.
Figure 4.39 Exponential Shape Design With 12 Design Variables: Iteration 126
Figure 4.40 Exponential Shape Design With 12 Design Variables: Iteration 127
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Figure 4.41 Exponential Shape Design With 12 Design Variables: Iteration 128
Figure 4.42 shows the convergence of the cost for the design process and Figure 4.43 shows
the corresponding areas. This shape quickly converged to an optimal family of configurations
which have very low costs and all of the areas observed satisfied the area constraint, making
this a good candidate for an improved stent shape.
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Figure 4.42 Convergence of Design of the Exponential Stent Using 12 Design Variables
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Figure 4.43 Area of Designs of the Exponential Stent Using 12 Design Variables
Design of the Airfoil Shaped Stent
Airfoils are very streamlined and so the shape was considered as a possibility for stent
design. Since the Hicks-Henne functions were developed for use with airfoils, only 8 design
variables were used for this case. Figures 4.44 - 4.48 show the first 5 valid meshes produced
in the design process. All of these shapes are airfoil-like with differences in the height of
the peak. They all also have a final dip below the level of the blood vessel wall, similar to
the exponential shaped designs. Although the recirculation zone at the front edge of the
stent is more pronounced than in other cases, several of these early designs have virtually
no recirculation at the back of the stent, which is where most of the problems contributing
to restenosis occur.
58
Figure 4.44 Airfoil Shape Design With 8 Design Variables: Iteration 7
Figure 4.45 Airfoil Shape Design With 8 Design Variables: Iteration 23
Figure 4.46 Airfoil Shape Design With 8 Design Variables: Iteration 29
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Figure 4.47 Airfoil Shape Design With 8 Design Variables: Iteration 33
Figure 4.48 Airfoil Shape Design With 8 Design Variables: Iteration 35
Figures 4.49 - 4.51 show the final 3 meshes produced in the design process. These shapes
are very similar to one another. These later designs do not dip below the level of the blood
vessel wall, indicating the Dakota is designing away from that option. This shape has a
region of very high velocity along the front of the stent and also a very large recirculation
zone at the front. Unfortunately the mesh is inverted at the leading edge of the stent,
indicating that there needs to be improved analysis of mesh quality in the code.
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Figure 4.49 Airfoil Shape Design With 8 Design Variables: Iteration 218
Figure 4.50 Airfoil Shape Design With 8 Design Variables: Iteration 219
Figure 4.51 Airfoil Shape Design With 8 Design Variables: Iteration 220
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Figure 4.52 shows the convergence of the design process. As with the exponential shape,
the naturally streamlined initial shape of the airfoil also produced lower values of cost.
Figure 4.53 shows the areas corresponding to each of the cost function evaluations. In
the figure a reference line has been drawn to indicate the area constraint. Although there
was a decreasing trend for the areas observed, many were above the threshold. If further
constraints were placed on the shape to ensure the mesh would not be inverted, this case may
produce results which meet the area constraint. However, unless the recirculation zone at
the leading edge of the stent is greatly reduced, this cannot be considered a good candidate
for an improved stent shape.
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Figure 4.52 Convergence of Design of the Airfoil Stent Using 8 Design Variables
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Figure 4.53 Area of Designs of the Airfoil Stent Using 8 Design Variables
Design of the Stent Starting from a Flat Curve
The ideal scenario for improving shear rate and shear stress is to have no stent in the
blood vessel, which is usually not the case after PCI treatment. It was decided to use the
true ideal scenario as a starting place for design to see if the random initial population of the
evolutionary algorithm and the area constraint would be enough to find a valid option which
improves the stent design. Figures 4.54 - 4.58 show the first 5 valid meshes produced in the
design process. These images identify two different design options, one that is symmetric
and curved and another that is a plateau shape with a slight dip in the center.
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Figure 4.54 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 1
Figure 4.55 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 2
Figure 4.56 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 7
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Figure 4.57 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 11
Figure 4.58 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 15
Figures 4.59 - 4.61 show the final 3 meshes produced in the design process. This case
converged to a somewhat symmetric shape with very little recirculation in either the front
or the back of the stent. This shape is most similar to that produced using the exponential
initial mesh, but the height of the stent is much lower. This shape also has a slight bump
at the trailing edge of the stent. This is likely a remnant of the evolutionary process rather
than an optimized design since the stent would still have very little recirculation without it.
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Figure 4.59 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 143
Figure 4.60 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 144
Figure 4.61 Stent Design Starting from a Flat Plate With 8 Design Variables: Iteration 146
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Figure 4.62 shows the convergence of the designing using 12 design variables and a flat
starting position and Figure 4.63 shows the corresponding areas. The cost in general is very
low, with many around or below a value of 10, however this case produced the smallest
areas thus far observed. Therefore improvements need to be made in the constraints used to
ensure proper area or height for the stent.
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Figure 4.62 Convergence of Stent Design Starting from a Flat Plate Using 12 Design
Variables
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Figure 4.63 Area of Stent Designs Starting from a Flat Plate Using 12 Design Variables
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CHAPTER 5
CONCLUSIONS
The goal of this work was to implement a two-dimensional, compressible flow solver that
is capable of simulating blood flow through stented arteries and then to interface the flow
solver and a mesh movement routine with Dakota to improve arterial stent design. The
ability to simulate blood flow was verified by comparing the results to analytic solutions
of the Blasius equation and Couette flow and by comparing results of simulations through
stented arteries to results found in other studies. The flow solver was linked with linear
elastic mesh movement and an interface was created with Dakota.
Candidate stent designs were found by Dakota using initial meshes with elliptical,
exponential, airfoil, and flat shaped stent sections. All of the resulting candidate stent
shapes differed greatly from one another, indicating that the results are highly dependent on
the initial shape used for the design process. Regardless of the number of design variables
used, the elliptical shape failed to produce low costs and never met area constraint. The
exponential shape produced results with low costs, areas above the constraint, and reduced
recirculation zones. The airfoil shape nearly met the area costraint and also had low costs,
but the recirculation zone at the leading edge was more pronounced and the final meshes
were inverted at the leading edge. The flat shape produced the lowest costs overall, but
failed to meet the area constraint. Thus the only the exponential shape can be considered a
good candidate for improving stent design.
Improvements can be made to the design process in several areas. The flow solver
will more accurately simulate blood flow when incompressibility, the extension to three
dimensions, and the ability to model pulsatile flow are added. The computational time could
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be reduced by adding parallelism and the ability to compute derivatives needed for gradient-
based optimization methods. The results obtained here would provide a good starting place
for gradient-based methods. Furthermore, since the designs obtained using Hicks-Henne
functions are dependent upon the initial mesh and there are some issues with smoothness
using this parametrization, other forms of parametrization should be considered which do not
have this dependency and better satisfy smoothness requirements. Finally, the recirculation
zones were not entirely eliminated, especially in the airfoil case, indicating that the cost
function needs improvment. This is due to the fact that although the flow is in the wrong
direction, the shear rate is still relatively high in most of the recirculation zone and is
only low at the reattachment point. Incorporating a directional component into the cost
function would allow the design process to directly minimize the recirculation zones as well
as maximizing shear rate.
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APPENDIX A
DAKOTA INPUT FILE
73
Below is an example of the Dakota input file used in this study. Although this study only
used the evolutionary algorithm, identified as ‘EA’, this input file is also set up to handle the
OPT++ quasi-Newton method, identified as method ‘NLP’. Each method requires a model
which identifies the appropriate variables, interface, and responses. If Dakota is to use an
outside source for the function evaluations, this information needs to be specified in the
interface section. Every time a function evaluation is required, Dakota will print the request
in the parameters file specified, call the specified analysis driver, and wait for the driver to
return the specified results file. The responses section identifies the number of cost functions
and any constraints. It may be advantageous to use a combination of methods to solve the
problem. For instance, Dakota could use evolutionary algorithm to find an interval which
contains the solution and then switch to the Newton method to quickly find that solution.
Although not shown here, this can all be specified in the strategy section of the input file.
# DAKOTA INPUT FILE
strategy,
hybrid sequential
method_list = ‘EA’
#graphics
tabular_graphics_data
method,
id_method = ‘EA’
model_pointer = ‘M1’
max_iterations = 30
coliny_ea
seed = 101
population_size = 10
crossover_rate = 1.0
crossover_type = blend
mutation_type = offset_normal
mutation_scale = 0.0001
replacement_type chc = 3
final_solution = 1
output debug
method,
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id_method = ‘NLP’
model_pointer = ‘M2’
optpp_q_newton
max_iterations = 100
convergence_tolerance = 1e-8
#max_step = 10.0
search_method value_based_line_search
output debug
model,
id_model = ‘M1’
single
variables_pointer = ‘V1’
interface_pointer = ‘I1’
responses_pointer = ‘R1’
model,
id_model = ‘M2’
single
variables_pointer = ‘V1’
interface_pointer = ‘I1’
responses_pointer = ‘R2’
variables,
id_variables = ‘V1’
continuous_design = 15
cdv_initial_point 0.00 0.1 -0.1 0.00 0.00 0.00 0.00 0.00
cdv_lower_bounds -0.02 -0.02 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05
cdv_upper_bounds 0.02 0.05 0.10 0.10 0.10 0.10 0.10 0.10
cdv_descriptor ’h0’ ’h1’ ’h2’ ’h3’ ’h4’ ’h5’ ’h6’ ’h7’
interface,
id_interface = ‘I1’
system
#asynchronous
analysis_driver = ‘driver_script.py’
parameters_file = ‘params.in’
results_file = ‘results.out’
#aprepro
#deactivate active_set_vector
file_tag # tag files with design cycle number
#file_save # don’t delete old design cycle files
responses,
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id_responses = ‘R1’
num_objective_functions = 1
num_nonlinear_inequality_constraints = 1
nonlinear_inequality_lower_bounds = 1.0e-8
no_gradients
no_hessians
responses,
id_responses = ‘R2’
num_objective_functions = 1
num_nonlinear_inequality_constraints = 1
nonlinear_inequality_lower_bounds = 1.0e-8
#numerical_gradients
#fd_gradient_step_size = .000001
# to instead use analytic gradients returned by the simulator comment the
# preceding two lines and uncomment the following:
analytic_gradients
no_hessians
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